2-MethylaminoethanolCAS# 109-83-1 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 109-83-1 | SDF | Download SDF |
PubChem ID | 8016 | Appearance | Cryst. |
Formula | C3H9NO | M.Wt | 75.11 |
Type of Compound | Alkaloids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 2-(methylamino)ethanol | ||
SMILES | CNCCO | ||
Standard InChIKey | OPKOKAMJFNKNAS-UHFFFAOYSA-N | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
In vitro | Effect of Amino Alcohols and their Phosphoryl Compounds on the Growth of Experimentally Transplantable Cancer.[Reference: WebLink]Chemical & Pharmaceutical Bulletin, 2008,8 (10) :900-903
|
Structure Identification | Journal of Molecular Spectroscopy,1975,56(2):229-238.Hydrogen bonding and conformational equilibrium of 2-methylaminoethanol by microwave spectroscopy[Reference: WebLink]
|
2-Methylaminoethanol Dilution Calculator
2-Methylaminoethanol Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 13.3138 mL | 66.569 mL | 133.1381 mL | 266.2761 mL | 332.8452 mL |
5 mM | 2.6628 mL | 13.3138 mL | 26.6276 mL | 53.2552 mL | 66.569 mL |
10 mM | 1.3314 mL | 6.6569 mL | 13.3138 mL | 26.6276 mL | 33.2845 mL |
50 mM | 0.2663 mL | 1.3314 mL | 2.6628 mL | 5.3255 mL | 6.6569 mL |
100 mM | 0.1331 mL | 0.6657 mL | 1.3314 mL | 2.6628 mL | 3.3285 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Butylamine
Catalog No.:BCC8304
CAS No.:109-73-9
- Allylthiourea
Catalog No.:BCC4759
CAS No.:109-57-9
- N-Valeric acid
Catalog No.:BCC8220
CAS No.:109-52-4
- FURA-2AM
Catalog No.:BCC7296
CAS No.:108964-32-5
- Neocurdione
Catalog No.:BCC9242
CAS No.:108944-67-8
- H-7 dihydrochloride
Catalog No.:BCC6686
CAS No.:108930-17-2
- GSK1904529A
Catalog No.:BCC1062
CAS No.:1089283-49-7
- U0124
Catalog No.:BCC7200
CAS No.:108923-79-1
- Soyasaponin IV
Catalog No.:BCN1627
CAS No.:108906-97-4
- MK 6096
Catalog No.:BCC4020
CAS No.:1088991-73-4
- GSK-923295
Catalog No.:BCC1608
CAS No.:1088965-37-0
- 13-O-Acetylcorianin
Catalog No.:BCN5883
CAS No.:108887-44-1
- Ilexoside K
Catalog No.:BCN7866
CAS No.:109008-26-6
- Ilexoside D
Catalog No.:BCN7865
CAS No.:109008-27-7
- Mauritianin
Catalog No.:BCN2932
CAS No.:109008-28-8
- CGS 12066B dimaleate
Catalog No.:BCC6732
CAS No.:109028-10-6
- Schizanthine E
Catalog No.:BCN1937
CAS No.:109031-04-1
- Icariside B1
Catalog No.:BCN7271
CAS No.:109062-00-2
- 2-(Chloromethyl)-4-methylquinazoline
Catalog No.:BCC8482
CAS No.:109113-72-6
- Boc-Chg-OH
Catalog No.:BCC3163
CAS No.:109183-71-3
- Tachioside
Catalog No.:BCN5884
CAS No.:109194-60-7
- 3,4,5-Trimethoxyphenyl-(6-O-galloyl)-O-beta-D-glucopyranoside
Catalog No.:BCN7272
CAS No.:109206-94-2
- ent-11beta-Hydroxyatis-16-ene-3,14-dione
Catalog No.:BCN6600
CAS No.:1092103-22-4
- Camellianin A
Catalog No.:BCN7864
CAS No.:109232-77-1
Molecular Dynamics Study of the Solution Structure, Clustering, and Diffusion of Four Aqueous Alkanolamines.[Pubmed:29446633]
J Phys Chem B. 2018 Mar 15;122(10):2769-2778.
CO2 sequestration from anthropogenic resources is a challenge to the design of environmental processes at a large scale. Reversible chemical absorption by amine-based solvents is one of the most efficient methods of CO2 removal. Molecular simulation techniques are very useful tools to investigate CO2 binding by aqueous alkanolamine molecules for further technological application. In the present work, we have performed detailed atomistic molecular dynamics simulations of aqueous solutions of three prototype amines: monoethanolamine (MEA) as a standard, 3-aminopropanol (MPA), 2-Methylaminoethanol (MMEA), and 4-diethylamino-2-butanol (DEAB) as potential novel CO2 absorptive solvents. Solvent densities, radial distribution functions, cluster size distributions, hydrogen-bonding statistics, and diffusion coefficients for a full range of mixture compositions have been obtained. The solvent densities and diffusion coefficients from simulations are in good agreement with those in the experiment. In aqueous solution, MEA, MPA, and MMEA molecules prefer to be fully solvated by water molecules, whereas DEAB molecules tend to self-aggregate. In a range from 30/70-50/50 (w/w) alkanolamine/water mixtures, they form a bicontinuous phase (both alkanolamine and water are organized in two mutually percolating clusters). Among the studied aqueous alkanolamine solutions, the diffusion coefficients decrease in the following order MEA > MPA = MMEA > DEAB. With an increase of water content, the diffusion coefficients increase for all studied alkanolamines. The presented results are a first step for process-scale simulation and provide important qualitative and quantitative information for the design and engineering of efficient new CO2 removal processes.
The endogenous brain constituent N-arachidonoyl L-serine is an activator of large conductance Ca2+-activated K+ channels.[Pubmed:18923087]
J Pharmacol Exp Ther. 2009 Jan;328(1):351-61.
The novel endocannabinoid-like lipid N-arachidonoyl L-serine (ARA-S) causes vasodilation through both endothelium-dependent and -independent mechanisms. We have analyzed the vasorelaxant effect of ARA-S in isolated vascular preparations and its effects on Ca(2+)-activated K(+) currents in human embryonic kidney cells stably transfected with the alpha-subunit of the human, large conductance Ca(+)-activated K(+) (BK(Ca)) channel [human embryonic kidney (HEK) 293hSlo cells]. ARA-S caused relaxation of rat isolated, intact and denuded, small mesenteric arteries preconstricted with (R)-(-)-1-(3-hydroxyphenyl)-2-Methylaminoethanol hydrochloride (pEC(50), 5.49 and 5.14, respectively), whereas it caused further contraction of vessels preconstricted with KCl (pEC(50), 5.48 and 4.82, respectively). Vasorelaxation by ARA-S was inhibited by 100 nM iberiotoxin. In human embryonic kidney cells stably transfected with the alpha-subunit of the human BK(Ca) channel cells, ARA-S and its enantiomer, N-arachidonoyl-D-serine, enhanced the whole-cell outward K(+) current with similar potency (pEC(50), 5.63 and 5.32, respectively). The potentiation was not altered by the beta(1) subunit or mediated by ARA-S metabolites, stimulation of known cannabinoid receptors, G proteins, protein kinases, or Ca(2+)-dependent processes; it was lost after patch excision or after membrane cholesterol depletion but was restored after cholesterol reconstitution. BK(Ca) currents were also enhanced by N-arachidonoyl ethanolamide (pEC(50), 5.27) but inhibited by another endocannabinoid, O-arachidonoyl ethanolamine (pIC(50), 6.35), or by the synthetic cannabinoid O-1918 [(-)-1,3-dimethoxy-2-(3-3,4-trans-p-menthadien-(1,8)-yl)-orcinol] (pIC(50), 6.59), which blocks ARA-S-induced vasodilation. We conclude the following. 1) ARA-S directly activates BK(Ca) channels. 2) This interaction does not involve cannabinoid receptors or cytosolic factors but is dependent on the presence of membrane cholesterol. 3) Direct BK(Ca) channel activation probably contributes to the endothelium-independent component of ARA-S-induced mesenteric vasorelaxation. 4) O-1918 is a BK(Ca) channel inhibitor.